MedPath

IRCCS Azienda Ospedaliero-Universitaria di Bologna

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

449

Active:33
Completed:122

Trial Phases

4 Phases

Phase 2:13
Phase 3:4
Phase 4:15
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (148 trials with phase data)• Click on a phase to view related trials

Not Applicable
116 (78.4%)
Phase 4
15 (10.1%)
Phase 2
13 (8.8%)
Phase 3
4 (2.7%)

Non-invasive Monitoring of Newborns in the First Hours of Life for the Prevention of SUPC (Sudden Unexpected Postnatal Collapse): Interventional Study With Medical Device

Not Applicable
Not yet recruiting
Conditions
Sudden Unexpected Postnatal Collapse -SUPC
First Posted Date
2025-10-08
Last Posted Date
2025-10-08
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Target Recruit Count
5000
Registration Number
NCT07213401
Locations
🇮🇹

Irccs Aoubo, Bologna, BO, Italy

Attitudes and Decision Regret Regarding Fertility Preservation in Transgender Individuals

Completed
Conditions
Fertility Preservation in Transgender Persons
First Posted Date
2025-09-26
Last Posted Date
2025-09-26
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Target Recruit Count
616
Registration Number
NCT07194226
Locations
🇮🇹

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, BO, Italy

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Recruiting
Conditions
Gender Incongruence
Cardiovascular (CV) Risk
Cardiovascular Health Status
Cardiovascular Disease (CVD)
Cardiovascular Disease Prevention
Cardiovascular Disease Risk Factor
Cardiovascular Disease Acute
Interventions
Drug: Feminizing GAHT
Drug: Masculinizing GAHT
First Posted Date
2025-09-23
Last Posted Date
2025-09-23
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Target Recruit Count
500
Registration Number
NCT07187947
Locations
🇮🇹

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, BO, Italy

The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients

Not Applicable
Recruiting
Conditions
Non Small Cell Lung Cancer NSCLC
First Posted Date
2025-09-23
Last Posted Date
2025-09-23
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Target Recruit Count
10
Registration Number
NCT07188480
Locations
🇮🇹

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna, Italy

The LungVision Navigational Platform for Preoperative Labeling of Pulmonary Ground Glass Nodules With Fiducial Markers

Not Applicable
Recruiting
Conditions
Lung Cancer
First Posted Date
2025-09-18
Last Posted Date
2025-09-18
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Target Recruit Count
5
Registration Number
NCT07180823
Locations
🇮🇹

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 90
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.